Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03856099
Title TTAC-0001 Phase II Trial With Recurrent Glioblastoma Progressed on Bevacizumab
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors PharmAbcine
Indications

glioblastoma

gliosarcoma

Therapies

Tanibirumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.